CEBPA and acute myeloid leukemia: Mutations in the CEBPα gene occur in roughly 10% of AML patients (Pabst and Mueller, 2009), but there is confusion about whether CEBPα expression is low or high in patients’ cells (Pabst and Mueller, 2009; Gholami et al., 2019).